🟢 Quantum BioPharma is trading 5.8% up today after its ArcStone-Kingswood Growth Summit presentation

Quantum BioPharma is trading at $3.66 (+5.78%) after its September 16, 2026 presentation at the ArcStone-Kingswood Growth Summit.

• The presentation highlights recent milestones and the company’s future growth strategy.
• Investor interest is also supported by FDA clearance to begin Phase 2 Lucid-MS trials.
• Broader Nasdaq strength adds supportive risk sentiment, while biotech weakness limits sector confirmation.